retatrutide energy boost is generating excitement—and it’s about more than appetite suppression., Healthcare providers have an opportunity to reframe the conversation around weight management., Retatrutide’s Retatrutide: A Multi-Receptor Approach to

Discussion In this cohort study, most patients with overweight or obesity discontinued GLP-1 RA therapy within 1 year, but those without type 2 diabetes had higher discontinuation rates and lower reinitiation rates

GLP-1s in the news Most recent: Weight Loss Drugs Like Ozempic Are Lowering the U.S

High-intensity exercise shifts fuel utilization toward glycogen, reducing the advantage of the pre-mobilized fatty acids

Understanding the new rules is the first step toward protecting your access to treatment

[...] PSM statement on deeply concerning compounding of GLP-1 weight-loss pills PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug